About
Vitruvias Therapeutics facilitated the distribution and commercialization of generic and authorized generic drugs in the U.S. market by partnering with small global pharmaceutical companies. The company has ceased operations, and its product portfolio is now managed by H2-Pharma LLC.
Explore Vitruvias Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.